Instructions

ZOOM IN by clicking on the page. A slider will appear, allowing you to adjust your zoom level. Return to the original size by clicking on the page again.

MOVE the page around when zoomed in by dragging it.

ADJUST the zoom using the slider on the top right.

ZOOM OUT by clicking on the zoomed-in page.

SEARCH by entering text in the search field and click on "In This Issue" or "All Issues" to search the current issue or the archive of back issues
respectively.

PRINT by clicking on thumbnails to select pages, and then press the
print button.

SHARE this publication and page.

ROTATE PAGE allows you to turn pages 90 degrees clockwise or counterclockwise.Click on the page to return to the original orientation. To zoom in on a rotated page, return the page to its original orientation, zoom in, and
then rotate it again.

CONTENTS displays a table of sections with thumbnails and descriptions.

ALL PAGES displays thumbnails of every page in the issue. Click on
a page to jump.

MEDICAL PARTNERSHIP
USAMMDA’s Combat Trauma and Acute Rehabilitation Proj-
ect Management Office has overseen numerous research projects
focused on developing novel solutions to address this need.
Currently, the most successful projects in its portfolio are efforts
in the field of vascularized composite allotransplantation, which
involves hand and face transplants, and the ongoing development
of a skin substitute to treat burn wounds.
BioFabUSA is focused on tissue engineering, at manufac-
turing readiness levels between 4 (validated in a laboratory
environment) and 7 (demonstrated in prototype in an oper-
ational setting), said Eaton. The group hopes to research
immature technologies to see if these can be scaled up, or scaled
out, to ensure a consistent quality of tissue manufacturing.
“We have more than 100 members within the various industries
and academia and private partners that have joined the institute,
and these will add over $200 million in private commitments,”
she said. “BioFabUSA is currently working with these partners
to set up a tissue foundry so they can create test facilities where
the partners can come in and learn how to scale up some of their
own products.
“Our goal,” Eaton explained, “ is to ensure that these public-
private partnerships are sustainable, so that after the government
funding ends, the institute can continue on its own as a sustain-
able entity. In the end, we want to make sure we have those
manufacturing partnerships in place with these industry
partners.”
Eaton values the open campus concept, as it allows USAMMDA
to reach out to more partners than it could on its own. She
believes it is helping the organization connect with researchers in
academia as well as its usual partners in the commercial indu s t r y.
“We have a lot of partners in industry and academia that want
to support the DOD, but they just don’t know how—and we’re
able to provide them with our unmet needs and capabilities so
they can provide support to the DOD,” she said.
“At the same time, we’re providing them with our expertise, and
they are able to work with our science and technology partners
and tap into some of our military populations for clinical trials,
if they would like to study the effects on our unique population,”
While USAMMDA does its part
in the development of critical
medical products moving
through the acquisition pipeline,
it relies heavily on commercial
partners in industry to complete
this important task.
READY, FAST AND EASY
Andrew Atkinson, product manager for USAMMDA’s PSPMO,
demonstrates the speed and ease of reconstituting freeze - dried
human blood plasma during an Army senior leadership visit at
Fort Detrick in March 2018. Produced through a successful effort
between USAMMDA and its industry partners, the freeze - dried
plasma product could be approved and readily available for use
by 2020. (Photo by Ashley Force, USAMMDA Public Affairs)
64
Army AL&T Magazine
January-March 2019